Research Topics
Species | C R RinaldoSummaryAffiliation: University of Pittsburgh Country: USA Publications
Research Grants
| Collaborators
|
Detail Information
Publications
Dendritic cell-based human immunodeficiency virus vaccineC R Rinaldo
Department of Infectious Diseases, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, PA 15261, USA
J Intern Med 265:138-58. 2009..The objective is to define a safe and effective strategy for enhancing control of HIV infection in patients undergoing antiretroviral therapy...
Virus infection of dendritic cells: portal for host invasion and host defenseCharles R Rinaldo
Department of Infectious Diseases and Microbiology and Department of Pathology, University of Pittsburgh, Pittsburgh, PA 15261, USA
Trends Microbiol 12:337-45. 2004..Engineering of DCs with various forms of viral immunogens and co-treatment with cytokines and chemokines is being used as an immunotherapy for HIV-1 and other viral infections...
Passive immunization against poliomyelitis: the Hammon gamma globulin field trials, 1951-1953Charles R Rinaldo
Department of Infectious Diseases, University of Pittsburgh Graduate School of Public Health, School of Public Health, PA 15261, USA
Am J Public Health 95:790-9. 2005..This study provided the first evidence that antibodies to poliovirus could prevent the disease in humans...
Prolonged suppression of human immunodeficiency virus type 1 (HIV-1) viremia in persons with advanced disease results in enhancement of CD4 T cell reactivity to microbial antigens but not to HIV-1 antigensC R Rinaldo
Deptartment of Infectious Diseases and Microbiology, University of Pittsburgh Graduate School of Public Health, Pittsburgh, PA 15261, USA
J Infect Dis 179:329-36. 1999..Prolonged indinavir-zidovudine-lamivudine treatment has significant but incomplete enhancing effects on CD4 T cell reactivity, which could be important in host control of microbial and persistent HIV-1 infections...
Anti-human immunodeficiency virus type 1 (HIV-1) CD8(+) T-lymphocyte reactivity during combination antiretroviral therapy in HIV-1-infected patients with advanced immunodeficiencyC R Rinaldo
Graduate School of Public Health, Pittsburgh, Pennsylvania 15261, USA
J Virol 74:4127-38. 2000..These results indicate that new strategies will be needed to target residual, immunocompetent HIV-1-specific CD8(+) T cells to enhance the effectiveness of antiretroviral therapy in patients with advanced immunodeficiency...
High viral load in semen of human immunodeficiency virus type 1-infected men at all stages of disease and its reduction by therapy with protease and nonnucleoside reverse transcriptase inhibitorsP Gupta
Department of Infectious Diseases and Microbiology, Graduate School of Public Health, University of Pittsburgh, and Veterans Affairs Medical Center, Pennsylvania, USA
J Virol 71:6271-5. 1997..These findings have important implications for the biology of sexual transmission of HIV-1 and its potential reduction by antiretroviral therapy...
Primary human herpesvirus 8 infection generates a broadly specific CD8(+) T-cell response to viral lytic cycle proteinsQ J Wang
Department of Infectious Diseases and Microbiology, Graduate School of Public Health, University of Pittsburgh, Pennsylvania 15261, USA
Blood 97:2366-73. 2001..CD8(+) T-cell responses to HHV-8 decreased by 2 to 3 years after primary infection. This antiviral T-cell response may control initial HHV-8 infection and prevent development of disease...
Maturation of dendritic cells for enhanced activation of anti-HIV-1 CD8(+) T cell immunityXiao li Huang
Graduate School of Public Health and School of Medicine, University of Pittsburgh, Pittsburgh, PA 15261, USA
J Leukoc Biol 83:1530-40. 2008..Thus, DC from HIV-1-infected subjects can be engineered with CD40L or a poly(I:C)-cytokine combination for enhancing CD8(+) T cell responses to HIV-1, which has potential applications in HIV-1 immunotherapy...
Processing and presentation of exogenous HLA class I peptides by dendritic cells from human immunodeficiency virus type 1-infected personsXiao-Li Huang
University of Pittsburgh Graduate School of Public Health, 130 DeSoto St, Pittsburgh, PA 15261, USA
J Virol 79:3052-62. 2005..This conclusion supports the use of DCs loaded with synthetic peptides in immunotherapy of HIV-1 infection...
Human immunodeficiency virus type 1 Vpr impairs dendritic cell maturation and T-cell activation: implications for viral immune escapeBiswanath Majumder
Department of Infectious Diseases and Microbiology, University of Pittsburgh Graduate School of Public Health, 130 DeSoto Street, Pittsburgh, Pennsylvania 15261, USA
J Virol 79:7990-8003. 2005..Taken together, these results indicate that HIV-1 Vpr may in part be responsible for HIV-1 immune evasion by inhibiting the maturation of costimulatory molecules and cytokines essential for immune activation...
Dendritic cell function during chronic hepatitis C virus and human immunodeficiency virus type 1 infectionZheng Fan
Graduate School of Public Health and School of Medicine, University of Pittsburgh, Pittsburgh, PA 15261, USA
Clin Vaccine Immunol 14:1127-37. 2007..DCs from these infected subjects have a normal capacity to stimulate CD4+ T cells. The functional effectiveness of DCs derived from HCV-infected individuals provides a rationale for the DC-based immunotherapy of chronic HCV infection...
Therapeutic immunization with human immunodeficiency virus type 1 (HIV-1) peptide-loaded dendritic cells is safe and induces immunogenicity in HIV-1-infected individualsNancy C Connolly
Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA 15213, USA
Clin Vaccine Immunol 15:284-92. 2008..DC vaccination was safe, was feasible, and showed promise of immunogenicity in ART-treated, HIV-1-positive individuals. Additional studies of DC immunization strategies for HIV-1 infection are warranted...
Human herpesvirus 8 infects and replicates in primary cultures of activated B lymphocytes through DC-SIGNGiovanna Rappocciolo
Department of Infectious Diseases and Microbiology, Graduate School of Public Health, University of Pittsburgh, 604 Parran Hall, 130 De Soto St, Pittsburgh, PA 15261, USA
J Virol 82:4793-806. 2008..Thus, the expression of DC-SIGN is essential for productive HHV-8 infection of and replication in B cells...
Proinflammatory cytokines in HIV disease-a review and rationale for new therapeutic approachesNancy C Connolly
University of Pittsburgh, Pittsburgh, PA 15213, USA
AIDS Rev 7:168-80. 2005..This review presents what is known about the dysregulation of proinflammatory cytokines in HIV-1 infection, highlighting newly available immune-based therapies that could augment antiretroviral drug therapies...
DC-SIGN is a receptor for human herpesvirus 8 on dendritic cells and macrophagesGiovanna Rappocciolo
Department of Infectious Diseases and Microbiology, Graduate School of Public Health, University of Pittsburgh, PA 15261, USA
J Immunol 176:1741-9. 2006..We propose that DC-SIGN serves as a portal for immune dysfunction and oncogenesis caused by HHV-8 infection...
Priming of human immunodeficiency virus type 1 (HIV-1)-specific CD8+ T cell responses by dendritic cells loaded with HIV-1 proteinsXiao-Li Huang
Graduate School of Public Health, University of Pittsburgh, Pennsylvania 15261, USA
J Infect Dis 187:315-9. 2003..Whole HIV-1 protein in liposome may be an effective immunogen for HIV-1 vaccine protocols...
Herpesvirus infections in organ transplant recipientsFrank J Jenkins
Department of Pathology and Infectious Diseases, University of Pittsburgh School of Medicine, Graduate School of Public Health, University of Pittsburgh Cancer Institute, Pittsburgh, Pennsylvania 15261, USA
Clin Diagn Lab Immunol 10:1-7. 2003
CD8+ T-cell immunity to HIV infectionPaolo Piazza
Department of Infectious Diseases and Microbiology, University of Pittsburgh Graduate School of Public Health, 425 Parran Hall, Pittsburgh, PA 15261, USA
Clin Lab Med 22:773-97. 2002..Knowledge of HIV-1-specific T-cell immunity and its role in protection from HIV-1 infection and disease must continue to expand until the goal of complete control of HIV-1 infection is accomplished...
Primary human immunodeficiency virus type 1-specific CD8+ T-cell responses induced by myeloid dendritic cellsBonnie A Colleton
Graduate School of Public Health1 and School of Medicine, 2 University of Pittsburgh, Pittsburgh, Pennsylvania 15261, USA
J Virol 83:6288-99. 2009..Thus, three major types of blood and tissue myeloid DC targeted by HIV-1, i.e., moDC, LC, and idDC, can prime multispecific, polyfunctional CD8(+) T-cell responses to HIV-1 and other viral antigens...
DC-SIGN on B lymphocytes is required for transmission of HIV-1 to T lymphocytesGiovanna Rappocciolo
Department of Infectious Diseases and Microbiology, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, Pennsylvania, USA
PLoS Pathog 2:e70. 2006..Transmission of HIV-1 from B cells to T cells through this DC-SIGN pathway could be important in the pathogenesis of HIV-1 infection...
Multiple T-cell responses to human immunodeficiency virus type 1 are enhanced by dendritic cellsXiao li Huang
Graduate School of Public Health and School of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania 15261, USA
Clin Vaccine Immunol 16:1504-16. 2009..These results indicate that DC can enhance multiple types of HIV-1-specific T-cell functions...
Levels of antigen processing machinery components in dendritic cells generated for vaccination of HIV-1+ subjectsNancy Connolly
Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA
AIDS 21:1683-92. 2007....
A phase I study of ampligen in human immunodeficiency virus-infected subjectsJ A Armstrong
Department of Infectious Diseases and Microbiology, Graduate School of Public Health, University of Pittsburgh, Pennsylvania
J Infect Dis 166:717-22. 1992..This effect of ampligen and the fact that it has been shown to act synergistically with zidovudine against HIV in vitro suggest that the combination might be tried clinically in patients...
Treating HIV-1 infection with dendritic cellsNancy C Connolly
University of Pittsburgh, School of Medicine and Graduate School of Public Health, 204 Craft Avenue, B501, Pittsburgh, PA 15213, USA
Curr Opin Mol Ther 9:353-63. 2007..This review focuses on HIV-1-DC interactions, the impact of these on DC therapeutics for the treatment of HIV-1-infected individuals and the current status of DC-based therapeutic vaccines for HIV-1 infection...
Activation of HIV type 1 specific cytotoxic T lymphocytes from semen by HIV type 1 antigen-presenting dendritic cells and IL-12Xiao-Li Huang
Graduate School of Public Health and School of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania 15261, USA
AIDS Res Hum Retroviruses 22:93-8. 2006..The DC-T cell system can serve as a model for immunotherapy of HIV-1 infection in the local genital tract as well as systemic blood circulation...
Production of a dendritic cell-based vaccine containing inactivated autologous virus for therapy of patients with chronic human immunodeficiency virus type 1 infectionTheresa L Whiteside
Department of Pathology, University of Pittsburgh School of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania 15213 1863, USA
Clin Vaccine Immunol 16:233-40. 2009..bb-ind-13137)...
Identification of an HLA A*0201-restricted CD8(+) T-cell epitope for the glycoprotein B homolog of human herpesvirus 8Qiong J Wang
Department of Infectious Diseases and Microbiology, Graduate School of Public Health, University of Pittsburgh, Pennsylvania 15261, USA
Blood 99:3360-6. 2002..This epitope may be important in control of HHV-8 infection by CD8(+) T cells...
Comparison of immunologic assays for detecting immune responses in HIV immunotherapeutic studies: AIDS Clinical Trials Group Trial A5181Bernard J C Macatangay
Division of Infectious Diseases HIV AIDS Unit, University of Pittsburgh School of Medicine, Pittsburgh, PA 15213, USA
Clin Vaccine Immunol 17:1452-9. 2010..These studies highlight complexities of immunologic monitoring of T-cell responses in multisite clinical trials in HIV infection and outline considerations for optimizing these efforts...
Induction of anti-human immunodeficiency virus type 1 (HIV-1) CD8(+) and CD4(+) T-cell reactivity by dendritic cells loaded with HIV-1 X4-infected apoptotic cellsXiao-qing Zhao
Department of Infectious Diseases and Microbiology, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, Pennsylvania 15261, USA
J Virol 76:3007-14. 2002..This may be an important mechanism of HIV-1 immunogenicity and provides a strategy for immunotherapy of HIV-1-infected patients on combination antiretroviral therapy...
Restoration of anti-human immunodeficiency virus type 1 (HIV-1) responses in CD8+ T cells from late-stage patients on prolonged antiretroviral therapy by stimulation in vitro with HIV-1 protein-loaded dendritic cellsZ Fan
Department of Infectious Diseases and Microbiology, Graduate School of Public Health, School of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania 15261, USA
J Virol 75:4413-9. 2001..This suggests that dendritic cells from HIV-1-infected persons can be engineered to evoke stronger anti-HIV-1 CD8+ T-cell reactivity as a strategy to augment antiretroviral therapy...
Cytokine production by human herpesvirus 8-infected dendritic cellsHeather R Hensler
Department of Infectious Diseases and Microbiology, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, PA 15261, USA
J Gen Virol 90:79-83. 2009..These results suggest an intentional skewing of cytokine production in HHV-8-infected DCs towards induction of a Th2 response...
CD27 and CD57 expression reveals atypical differentiation of human immunodeficiency virus type 1-specific memory CD8+ T cellsAki Hoji
Department of Infectious Diseases, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, PA 15261, USA
Clin Vaccine Immunol 14:74-80. 2007..This lack of normal CD8+ T-cell differentiation could contribute to the failure of cellular immune control of HIV-1 infection...
Human CD8+ T cells specific for influenza A virus M1 display broad expression of maturation-associated phenotypic markers and chemokine receptorsAki Hoji
Department of Infectious Diseases and Microbiology, Graduate School of Public Health and School of Medicine, University of Pittsburgh, Pittsburgh, PA 15261, USA
Immunology 115:239-45. 2005..A phenotypic profile based on these observations showed that there are both immature and mature memory CD8+ T cells specific for FluA...
Minimization of genetic distances by the consensus, ancestral, and center-of-tree (COT) sequences for HIV-1 variants within an infected individual and the design of reagents to test immune reactivityGirish S Kesturu
Thomas E. Starzl Transplantation Institute, Department of Surgery, School of Medicine, University of Pittsburgh, PA 15261, USA
Virology 348:437-48. 2006..COT or CON sequences derived from autologous virus samplings may be useful for increasing the sensitivity of assessments of immune reactivity against HIV...
Prevalence of chlamydia and gonorrhoea among a population of men who have sex with menR L Cook
University of Pittsburgh, PA 15213, USA
Sex Transm Infect 78:190-3. 2002....
Association of polymorphisms in human leukocyte antigen class I and transporter associated with antigen processing genes with resistance to human immunodeficiency virus type 1 infectionChenglong Liu
School of Public Health, University of California, Los Angeles, CA 90095, USA
J Infect Dis 187:1404-10. 2003..In multivariate logistic analysis, only the A*0205 subgroup (OR, 5.56; 95% CI, 1.34-23.10; P=.018) and the TAP2 Ala665 (OR, 2.22; 95% CI, 1.28-3.84; P=.005) were associated with resistance...
Lack of associations between HLA class II alleles and resistance to HIV-1 infection among white, non-Hispanic homosexual menChenglong Liu
School of Public Health, University of California, Los Angeles, CA 90095 1772, USA
J Acquir Immune Defic Syndr 37:1313-7. 2004..Other genetic factors in the HLA class II-TAP region of the major histocompatibility complex might be involved...
Successful outcome of human metapneumovirus (hMPV) pneumonia in a lung transplant recipient treated with intravenous ribavirinKashif Raza
Division of Infectious Diseases, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania 15213, USA
J Heart Lung Transplant 26:862-4. 2007..We report a case of hMPV pneumonia in a lung transplant recipient presenting with respiratory failure and sepsis syndrome. hMPV was diagnosed by polymerase chain reaction, and treated with intravenous ribavirin with a successful outcome...
Vascular risk factors, HIV serostatus, and cognitive dysfunction in gay and bisexual menJ T Becker
University of Pittsburgh School of Medicine, Pittsburgh, PA, USA
Neurology 73:1292-9. 2009..The purpose of this study was to evaluate the relationship between cognitive performance, risk factors for cardiovascular and cerebrovascular disease (CVD), and HIV infection in the era of highly active antiretroviral therapy...
Degeneracy and repertoire of the human HIV-1 Gag p17(77-85) CTL responseJune Kan-Mitchell
Karmanos Cancer Institute, Wayne State University School of Medicine, Detroit, MI 48201, USA
J Immunol 176:6690-701. 2006..This study suggests that agonist sequences can replace aberrantly immunogenic native epitopes for the rational design of vaccines targeting HIV-1...
Relationship of cytomegalovirus load assessed by real-time PCR to pp65 antigenemia in organ transplant recipientsSonali K Sanghavi
Clinical Virology Laboratory, University of Pittsburgh Medical Center, United States
J Clin Virol 42:335-42. 2008..Cytomegalovirus (CMV) infection in immunocompromised patients can lead to viremia associated with morbidity and mortality. Monitoring of viral loads in blood is critical for initiating and monitoring antiviral treatment...
Development and implementation of a direct detection, quantitation and validation system for class I MHC self-peptide epitopesJon A Weidanz
Department of Pharmaceutical Sciences, School of Pharmacy, Texas Tech University Health Sciences Center, Amarillo, Texas 79106, USA
J Immunol Methods 318:47-58. 2007..We therefore demonstrate the successful development and implementation of an integrated discovery and validation technology system for direct identification and confirmation of class I MHC-peptide epitopes on cells...
Effect of highly active antiretroviral therapy on multiple AIDS-defining illnesses among male HIV seroconvertersLauren E Cain
Department of Epidemiology, Bloomberg School of Public Health, Johns Hopkins University, 615 North Wolfe Street E7640, Baltimore, MD 21205, USA
Am J Epidemiol 163:310-5. 2006..34 (95% CI: 0.25, 0.45) relative to the reference calendar period. HAART protects against initial and subsequent AIDS-defining illnesses, whose inclusion in analysis markedly increased the precision of the estimated hazard ratio...
Repeat-region polymorphisms in the gene for the dendritic cell-specific intercellular adhesion molecule-3-grabbing nonintegrin-related molecule: effects on HIV-1 susceptibilityHuanliang Liu
Department of Laboratory Medicine, University of Washington School of Medicine, Seattle, Washington 98195 8070, USA
J Infect Dis 193:698-702. 2006..5% in high-risk HIV-1-seronegative individuals vs. 27.6% in HIV-1-seropositive individuals; P=.0291). These findings suggest that DC-SIGNR polymorphisms may influence susceptibility to HIV-1...
Predictive value of immunologic and virologic markers after long or short duration of HIV-1 infectionJanis V Giorgi
UCLA School of Medicine and Center for AIDS Research, Los Angeles, California 90095-1475, USA
J Acquir Immune Defic Syndr 29:346-55. 2002....
Prognostic value of HIV-1 RNA, CD4 cell count, and CD4 Cell count slope for progression to AIDS and death in untreated HIV-1 infectionJohn W Mellors
JAMA 297:2349-50. 2007
When to initiate highly active antiretroviral therapy: a cohort approachLinda Ahdieh-Grant
Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21205, USA
Am J Epidemiol 157:738-46. 2003..Furthermore, results suggest a potential threshold for HAART initiation in the neighborhood of 275 cells/microl...
Induction of mucosal protection against primary, heterologous simian immunodeficiency virus by a DNA vaccineDeborah Heydenburg Fuller
PowderJect Vaccines, Inc, Madison, Wisconsin 53711, USA
J Virol 76:3309-17. 2002..These results support further development of a DNA vaccine for protection against HIV...
Non-Hodgkin's B cell lymphoma in persons with acquired immunodeficiency syndrome is associated with increased serum levels of IL10, or the IL10 promoter -592 C/C genotypeElizabeth Crabb Breen
Department of Obstetrics and Gynecology, David Geffen School of Medicine, University of California, Los Angeles, CA 90095, USA
Clin Immunol 109:119-29. 2003..009), even when controlling for race (P = 0.006). These results suggest that elevated serum IL10 or the IL10 promoter -592 C/C genotype are associated with development of AIDS lymphoma...
Incidence and epidemiology of anal cancer in the multicenter AIDS cohort studyGypsyamber D'Souza
Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21205, USA
J Acquir Immune Defic Syndr 48:491-9. 2008..To examine the incidence and risk factors for anal cancer in a multicenter cohort of human immunodeficiency virus (HIV) positive and HIV-negative men who have sex with men followed between 1984 and 2006 (Multicenter AIDS Cohort Study)...
Impact of inversion of the CD4/CD8 ratio on the natural history of HIV-1 infectionJoseph B Margolick
Department of Molecular Microbiology and Immunology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21205, USA
J Acquir Immune Defic Syndr 42:620-6. 2006..HIV-1 infection is characterized by an inverted CD4/CD8 T-cell ratio, but the distribution of inversions over time after seroconversion and whether delay of inversion is associated with a favorable prognosis are not known...
Escape from the dominant HLA-B27-restricted cytotoxic T-lymphocyte response in Gag is associated with a dramatic reduction in human immunodeficiency virus type 1 replicationArne Schneidewind
Partners AIDS Research Center, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA
J Virol 81:12382-93. 2007....
Regulatory polymorphisms in the cyclophilin A gene, PPIA, accelerate progression to AIDSPing An
Laboratory of Genomic Diversity, Science Applications International Corporation Frederick, National Cancer Institute Frederick, Frederick, Maryland, United States of America
PLoS Pathog 3:e88. 2007..These results implicate regulatory PPIA polymorphisms as a component of genetic susceptibility to HIV-1 infection or disease progression, affirming the important role of PPIA in HIV-1 pathogenesis...
Prospective study of attitudinal and relationship predictors of sexual risk in the multicenter AIDS cohort studyDavid G Ostrow
David Ostrow and Associates, Chicago MACS Howard Brown Health Center and Northwestern University School of Medicine, 5455 N Sheridan Rd, Suite 1207, Chicago, IL 60640, USA
AIDS Behav 12:127-38. 2008..We conclude that HIV prevention efforts should target modifiable attitudes (reduced concern about HIV and safer sex fatigue) and increases in sexual risk-taking of MSM, particularly among HIV+ men having sex with serodiscordant partners...
Estimating the benefit of an HIV-1 vaccine that reduces viral load set pointSwati B Gupta
Merck Research Laboratories, West Point, PA, USA
J Infect Dis 195:546-50. 2007..5-1.25 log(10) copies/mL lower than the reference group. By quantifying the anticipated clinical benefits associated with a reduction in viral set point, these findings support the use of virologic end points in HIV-1 vaccine trials...
Effect of tuberculosis on the survival of HIV-infected men in a country with low tuberculosis incidenceHugo Lopez-Gatell
Directorate of Epidemiology, Ministry of Health, Mexico, Mexico
AIDS 22:1869-73. 2008..2-4.7). Results underscore the importance of avoiding TB by using preventive interventions such as treatment of latent TB infection, particularly in populations with a large prevalence of HIV/TB co-infected individuals...
Research Grants
- Dendritic Cell-Based Immunotherapy for HIV InfectionCharles Rinaldo; Fiscal Year: 2006..We believe that this novel immunotherapy strategy ideally fulfills the intent of the NIAID Integrated Preclinical/Clinical Program. ..
- CYTOTOXIC T CELL RESPONSES TO HHV-8Charles Rinaldo; Fiscal Year: 2007..This is important for development of therapies and prophylactic vaccines for HHV-8 infection. ..
- MULTICENTER AIDS COHORT STUDYCharles Rinaldo; Fiscal Year: 2007..abstract_text> ..
- ANTI-HIV T CELL RESPONSES DURING ANTIVIRAL DRUG THERAPYCharles Rinaldo; Fiscal Year: 2007..We propose that this DC-apoptotic cell model may be an ideal immunogen that contains all antigenic forms of HIV-1 and can be a vehicle for therapeutic immunization. ..
- CYTOTOXIC T CELL RESPONSES TO HHV-8Charles Rinaldo; Fiscal Year: 2006..This is important for development of therapies and prophylactic vaccines for HHV-8 infection. ..
- CYTOTOXIC T CELL RESPONSES TO HHV8Charles Rinaldo; Fiscal Year: 2002..Such information is also important for understanding the immune correlates of protection against HHV-8 infection as the basis for development of therapeutic regimens and prophylatic vaccines ..
- ANTIHIV T CELL RESPONSES DURING ANTIVIRAL DRUG THERAPYCharles Rinaldo; Fiscal Year: 1999....
- CYTOTOXIC T CELL RESPONSES TO HHV-8Charles Rinaldo; Fiscal Year: 2003..This is important for development of therapies and prophylactic vaccines for HHV-8 infection. ..
- ANTI-HIV T CELL RESPONSES DURING ANTIVIRAL DRUG THERAPYCharles Rinaldo; Fiscal Year: 2003..We believe that these new, novel antigen delivery systems and processing methods will be highly efficient at inducing a broad spectrum of anti-HIV-1 T cell responses in ART patients. ..
- CYTOTOXIC T CELL RESPONSES TO HHV-8Charles R Rinaldo; Fiscal Year: 2010..This study will provide important information on CD8 T cell immunity during HHV-8 infection for development of adequate treatment and prevention strategies for HHV-8 related cancers. ..
